Evidence map›Paper›PMID 42484729›Full record

ReviewInternational ophthalmology2026

Teleophthalmology for Retinal Disease Screening and Referral in Low- and Middle-Income Countries: A Case Overview of India.

Kristi Sharma, Krishna Shah, Rajiv Raman

Abstract readReview
PubMed Publisher
In one paragraph

Review in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristi SharmaThe Sankara Nethralaya Academy, Unit of Medical Research Foundation, Chennai, Tamil Nadu, India.
Krishna ShahDepartment of Contact Lens, Sankara Nethralaya, Unit of Medical Research Foundation, Chennai, Tamil Nadu, India. krishna.researchid@gmail.com.ORCID https://orcid.org/0009-0002-5878-7718
Rajiv RamanShri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Unit of Medical Research Foundation, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innovations like teleophthalmology have made great strides in improving access to care for patients with retinal disease by enabling prompt screening and referral, especially in underprivileged areas. This review highlights the growing role of teleophthalmology in addressing the burden of few retinal diseases like diabetic retinopathy (DR), age-related macular degeneration (ARMD), and retinopathy of prematurity (ROP), artificial intelligence (AI), electronic medical records (EMR) and portable imaging technologies have greatly increased the precision of detection and care coordination. Its scalability is further supported by high patient satisfaction and cost-effectiveness. Barriers to implementation, however, include inadequate training, data security concerns, limited infrastructure and upfront investment costs. We offer focused solutions to address existing gaps, drawing primarily on evidence and national teleophthalmology initiatives from India, which is presented as a representative LMIC case study. The findings may guide the development and scale-up of teleophthalmology services in other LMICs settings. Teleophthalmology can become the backbone of equitable retinal disease care delivery with appropriate policy support and standardization of processes involved. These findings have broader implications for teleophthalmology implementation in LMICs that face similar healthcare delivery challenges.

Indexed as

Developing CountriesMass ScreeningOphthalmologyReferral and ConsultationRetinal DiseasesTelemedicineHumansIndiaArtificial intelligence in ophthalmologyEye care access in IndiaPortable fundus imagingRemote screening, TelescreeningRetinal disease screeningTeleophthalmology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.